A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

Initiating FIT screening at ages 40-49 reduces CRC mortality by 39% and incidence by 21% compared to starting at age 50. CRC incidence is rising among younger populations, with a 500% increase in ...

The Colonox™ FIT Screening Test Kit aids in the detection of colorectal cancer and conditions such as diverticulitis, colitis, and colon polyps. The noninvasive test is simple to use, can be completed ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

Colonoscopy may be inconvenient and require planning, but the consequence and therapy for cancer is far more burdensome.

People invited to undergo FIT were more likely to participate in colorectal cancer screening compared with those invited to undergo colonoscopy. FIT was noninferior to colonoscopy for colorectal ...

Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates. The highest return rate was seen with a 2-week deadline. This intervention can be easily ...